TY  - JOUR
AU  - López-Rodríguez, Rosario
AU  - Ferreiro-Iglesias, Aida
AU  - Lima, Aurea
AU  - Bernardes, Miguel
AU  - Pawlik, Andrzej
AU  - Paradowska-Gorycka, Agnieszka
AU  - Świerkot, Jerzy
AU  - Slezak, Ryszard
AU  - Dolžan, Vita
AU  - González-Álvaro, Isidoro
AU  - Narváez, Javier
AU  - Cáliz, Rafael
AU  - Pérez-Pampín, Eva
AU  - Mera-Varela, Antonio
AU  - Vidal-Bralo, Laura
AU  - Acuña Ochoa, José Gorgonio
AU  - Conde, Carmen
AU  - Gómez-Reino, Juan J
AU  - González, Antonio
PY  - 2018
DO  - 10.1038/s41598-018-25634-y
UR  - http://hdl.handle.net/10668/12441
T2  - Scientific reports
AB  - About 70 genetic studies have already addressed the need of biomarkers to predict the response of patients with rheumatoid arthritis (RA) to methotrexate (MTX) treatment. However, no genetic biomarker has yet been sufficiently validated. Here, we...
LA  - en
KW  - Adult
KW  - Aged
KW  - Alleles
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - Biomarkers, Pharmacological
KW  - Female
KW  - Ferredoxin-NADP Reductase
KW  - Gene Frequency
KW  - Humans
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Polymorphism, Single Nucleotide
KW  - Severity of Illness Index
KW  - Treatment Outcome
KW  - White People
TI  - Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis.
TY  - research article
VL  - 8
ER  -